WEEDCA
Open
Back To Top
Last Updated: Nov 13, 2019 11:15 a.m. EST Delayed quote

$24.89

-0.53 -2.08%
Agriculture 1.34%
Previous Close
$25.42
Advanced Charting
  • $
  • %
  • Vol
Advanced Charting
45.09% vs Avg.
Volume: 827.3K 65 Day Avg. - 1.8M
Open: 25.25
Last: 24.89
24.56 Day Low/High 25.68
Day Range
24.56 52 Week Low/High 70.98

Your Watchlist

Customize MarketWatch

Have Watchlists? Log in to see them here or sign up to get started.

Symbol
Company
Price
Chg/Chg %
No Items in Watchlist

There are currently no items in this Watchlist.

No Saved Watchlists

Create a list of the investments you want to track.

Uh oh

Something went wrong while loading Watchlist.

Recently Viewed Tickers

No Recent Tickers

Visit a quote page and your recently viewed tickers will be displayed here.

Overview

Key Data

  • Open $25.25
  • Day Range 24.56 - 25.68
  • 52 Week Range 24.56 - 70.98
  • Market Cap $9.34B
  • Shares Outstanding 343.58M
  • Public Float 216.03M
  • Beta n/a
  • Rev. per Employee $150.14K
  • P/E Ratio n/a
  • EPS $-6.58
  • Yield n/a
  • Dividend n/a
  • Ex-Dividend Date n/a
  • Short Interest n/a
  • % of Float Shorted n/a
  • Average Volume 1.83M

Performance

5 Day
  • -2.97%
1 Month
  • -4.46%
3 Month
  • -41.60%
YTD
  • -32.10%
1 Year
  • -44.93%

Recent News

  • MarketWatch
  • WSJ
Read full story

Cronos turns lower after kicking off cannabis earnings with revenue miss

Read full story

People of color are reclaiming their place in a cannabis industry ‘built on the backs of people from marginalized communities’

Read full story

Cannabis earnings: How much worse can it get for underperforming weed companies?

Read full story

Walmart, weed and a couple of crucial tech earnings are coming your way

MKM lowers quarterly estimates for Canopy Growth and Aurora Cannabis ahead of Thursday earnings

MKM Partners lowered its quarterly estimates for Canadian cannabis companies Canopy Growth Corp. and Aurora Cannabis Inc. , and said he expects neither company will show much improvement in sales when they report earnings on Thursday. Analyst Bill Kirk cited three reasons for the cuts, namely that inventory being held at provinces is weighing on shipments from manufacturers, pricing is falling and lower prices won't help shift product because legal weed is still way more expensive than black market product. "While net sales estimates have come down for both since the end of August (-18% for Canopy and -25% for Aurora), we believe there is still some risk to revenue estimates and EBITDA estimates (EBITDA estimate only down 8% for Canopy)," Kirk wrote in a note to clients. "With sequential growth suddenly stalling/declining, we believe P&L de-leverage will negatively surprise (costs planned for growth, but no growth)." That will cause the bulls to revisit the industry's expectations about how quickly companies can attain profitability. "For instance, Aurora is unlikely to be EBITDA positive by June 2020 as consensus expects," he wrote. Kirk lowered his sales forecast for Canopy's fiscal second quarter to C$95.4 million ($72.1 million) from a previous C$114.5 million and compared with the consensus of C$101.5 million. For Aurora, he lowered his fiscal first-quarter sales forecast to C$92.2 million from a previous C$98.0 million and consensus of C$89.7 million. Kirk rates Canopy as neutral and Aurora as sell. Canopy's U.S.-listed shares were last down 0.7% premarket, while Aurora was up 0.3%.

Read full story

Short sellers are increasing bets on cannabis stocks even after summer selloff

Read full story

Ex-Canopy CEO Bruce Linton joins U.S. cannabis company Vireo Health

Read full story

Drake is trying to trademark Canada’s pot warning label, and may be in for a fight

Canopy Growth to launch wellness company with rapper Drake

Canadian cannabis company Canopy Growth Corp. said Thursday it is planning to launch a cannabis wellness company with local rapper Drake based in his hometown of Toronto. No financial details were available, but the company plans to share some in the coming weeks. Canopy's U.S.-listed shares rose 3.2% premarket but are down 28% in 2019, while the ETFMG Alternative Harvest ETF has fallen 23% and the S&P 500 has gained 23%.

Read full story

Back to Green: Cantor Fitzgerald says Canadian cannabis stocks have hit a bottom

Read full story

Aurora Cannabis covets California’s weed culture, but can’t pronounce one word correctly

Read full story

Cannabis stocks fall as Curaleaf becomes latest company to scale back a big acquisition

Read full story

Hexo stock slides another 6% to weigh on cannabis sector after job cuts prompt downgrade

Canopy Growth to provide medical cannabis to Luxembourg and UK

Canadian cannabis company Canopy Growth Corp. said MOnday it has become the exclusive supplier of medical cannabis to Luxembourg in a deal that extends through Dec. 31, 2021. Luxembourg launched a medical cannabis program by decriminalizing it for patients with severe unmet needs in 2018. The Duchy is also expected to fully legalize the production and consumption of recreational cannabis in the near term and may be the first European country to do so. Canopy will provide cannabis to the Duchy via its Spectrum Therapeutics subsidiary. Spectrum has also been granted a license to store and distribute medical cannabis-based products in the UK. The UK has had a medical program for less than a year. "We are actively working with regulators to find the best way to ensure we can deliver continuous treatment to patients within the framework," Cosmo Feilding Mellen, managing director of Spectrum in the UK said in a statement. Canopy's U.S.-listed shares rose 1.9% in premarket trade, but are down 25% in 2019, while the ETFMG Alternative Harvest ETF has fallen 21% and the S&P 500 has gained 19%.

Canopy Growth to provide medical cannabis to Luxembourg and UK

Canadian cannabis company Canopy Growth Corp. said MOnday it has become the exclusive supplier of medical cannabis to Luxembourg in a deal that extends through Dec. 31, 2021. Luxembourg launched a medical cannabis program by decriminalizing it for patients with severe unmet needs in 2018. The Duchy is also expected to fully legalize the production and consumption of recreational cannabis in the near term and may be the first European country to do so. Canopy will provide cannabis to the Duchy via its Spectrum Therapeutics subsidiary. Spectrum has also been granted a license to store and distribute medical cannabis-based products in the UK. The UK has had a medical program for less than a year. "We are actively working with regulators to find the best way to ensure we can deliver continuous treatment to patients within the framework," Cosmo Feilding Mellen, managing director of Spectrum in the UK said in a statement. Canopy's U.S.-listed shares rose 1.9% in premarket trade, but are down 25% in 2019, while the ETFMG Alternative Harvest ETF has fallen 21% and the S&P 500 has gained 19%.

Read full story

One year on, Canada’s legal cannabis market is down but not out

Read full story

Cannabis stocks a sea of red as Green Organic’s financing woes weigh

Canopy Growth's sale of AusCann stake shows a focus shift to core assets and profitability: Jefferies

Canopy Growth Corp.'s announcement earlier Tuesday that it has sold its 13.2% stake in Australian producer AusCann for proceeds of C$6 million ($4.8 million) is a sign that the Canadian company is starting to clear its balance sheet to focus more on core assets and attaining profitability, according to Jefferies. Analysts Owen Bennett and Ryan Tomkins said the increased focus ins welcome, but "we do wonder how much more cleaning up may have to come." The deal is immaterial to either cash of international positioning, they wrote in a note to clients. Canopy had C$2.3 billion of cash as of last quarter, and the Australian market is expected to be just 1% of the Canadian market next year. Canopy Chief Executive Mark Zekulin told the analysts at a July meeting that with all the M&A deals Canopy had conducted, the complexity in the business had become significant. "With Bruce Linton (the old CEO) often saying in interviews past a key part of his and Canopy's strategy was "go into a market, spend and dominate, and then do the same again", we wonder how many assets that have been acquired are indeed non core, especially as the cash Constellation gave Canopy often meant money was no object," they wrote, referring to the $4 billion investment made last year by the brewer of Corona beer. "Further, we wonder how much Canopy would get for these assets when it sells them?" They noted that Hiku, an all-stock deal that closed in September at C$600 million, has still produced minimal revenue. U.S.-listed shares of Canopy were up 6.6% Tuesday, but have fallen 25% in 2019, while the ETFMG Alternative Harvest ETF has fallen 22%, and the S&P 500 has gained about 20%.

Read full story

Hexo stock dives after downgrade, dragging cannabis sector lower

Canopy Growth sells its 13.2% stake in AusCann for C$6.3 million

Canopy Growth Corp. said Tuesday it has sold its 42 million-share stake in Australian cannabis company AusCann Group Holdings for 15 cents a share, raising total proceeds of C$6.3 million ($4.8 million). The trade was facilitated by Canaccord Australia. The stake was equal to 13.2% of AusCann. "The decision to divest our position in AusCann, which we obtained three years ago in exchange for support provided, will allow us to sharpen our focus on our wholly-owned operations in the market, while continuing to collaborate with our partners at AusCann," Canopy Chief Executive Mark Zekulin said in a statement. Shares rose 2.9% in premarket trade, but are down 30% in 2019, while the ETFMG Alternative Harvest ETF has fallen 26% and the S&P 500 has gained 18%.

Read full story

Pot Stocks Shine For Wrong Reason

on The Wall Street Journal
Read full story

Corona Distributor: Legal Weed in California a ‘Nonevent’ For Beer Sales

on The Wall Street Journal
Read full story

Justice Department’s Marijuana Reversal Puts Damper on Hot Stocks

on The Wall Street Journal
Read full story

America’s Most Popular Type of Beer Is in Free Fall

on The Wall Street Journal
Read full story

Big Brewer Makes a Play for Marijuana Beverages

on The Wall Street Journal
Read full story

Canadian Exchange Weighs Risks in Trading U.S. Marijuana Stocks

on The Wall Street Journal

Recent News

  • Other News
  • Press Releases

Canadian icons come together: Canopy Growth and Drake launch new cannabis wellness company

Canadian icons come together: Canopy Growth and Drake launch new cannabis wellness company

on CNW Group

/R E P E A T -- Canopy Growth to Announce Second Quarter Fiscal 2020 Financial Results/

/R E P E A T -- Canopy Growth to Announce Second Quarter Fiscal 2020 Financial Results/

on CNW Group

Canopy Growth to Announce Second Quarter Fiscal 2020 Financial Results

Canopy Growth to Announce Second Quarter Fiscal 2020 Financial Results

on CNW Group

Canopy Growth to Announce Second Quarter Fiscal 2020 Financial Results

Canopy Growth to Announce Second Quarter Fiscal 2020 Financial Results

on CNW Group

Fashion Meets Flower with Holt Renfrew x Tokyo Smoke Holiday Collaboration

Fashion Meets Flower with Holt Renfrew x Tokyo Smoke Holiday Collaboration

on CNW Group

Spectrum Therapeutics and Tree of Knowledge Announce Partnership to Educate and Support Healthcare Professionals

Spectrum Therapeutics and Tree of Knowledge Announce Partnership to Educate and Support Healthcare Professionals

on CNW Group

Ancient Medicines Bring Modern Value to Yield Growth Corp.

About two weeks ago, The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) completed the acquisition ...

on Baystreet.ca

Canopy Rivers Portfolio Company Awarded Health Canada Oil Licence

Canopy Rivers Portfolio Company Awarded Health Canada Oil Licence

on CNW Group

Stocks in play: Jushi Holdings Inc.

Announced the appointment of Ian Farrell as Vice President of Compliance and Pam Baxter as Vice President ...

on Baystreet.ca

European Update: Canopy Growth Secures Exclusive Opportunities in the UK & Luxembourg

European Update: Canopy Growth Secures Exclusive Opportunities in the UK & Luxembourg

on CNW Group

/R E P E A T -- Media Advisory - Hey, Brandon, thanks for all the love. Another Tokyo Smoke is rolling into town/

/R E P E A T -- Media Advisory - Hey, Brandon, thanks for all the love. Another Tokyo Smoke is rolling into town/

on CNW Group

Media Advisory - Hey, Brandon, thanks for all the love. Another Tokyo Smoke is rolling into town

Media Advisory - Hey, Brandon, thanks for all the love. Another Tokyo Smoke is rolling into town

on CNW Group

Canopy Growth Launches 27th Retail Banner Location: Welcome Tokyo Smoke - Brandon, Manitoba

Canopy Growth Launches 27th Retail Banner Location: Welcome Tokyo Smoke - Brandon, Manitoba

on CNW Group

Beyond Cannabis 2.0: Yield Growth’s Perfect Timing by Being Ahead of Crowd

Today is the one-year anniversary of Canada cementing itself in history as the first G20 country to ...

on Baystreet.ca

Houseplant Introduces New Product Formats And Increases Footprint Across Canada

Houseplant Introduces New Product Formats And Increases Footprint Across Canada

on CNW Group

Stocks in play: The Yield Growth Corp.

Announced the appointment of Amber Allen as Head of Sales for Yield Growth's North American retail distribution. ...

on Baystreet.ca

Canopy Growth Announces Sale of Stake in AusCann

Canopy Growth Announces Sale of Stake in AusCann

on CNW Group

Canopy Growth completes previously announced acquisition of Beckley Canopy Therapeutics

Canopy Growth completes previously announced acquisition of Beckley Canopy Therapeutics

on CNW Group

Cannabis 2.0: Is This ETF Discounted?

Before the 2015 federal election in Canada, cannabis stocks were prepping for a run that would christen ...

on Baystreet.ca

Stocks in play: The Yield Growth Corp.

Announced that its wholly owned subsidiary Flourish Mushroom Labs Inc. has completed the acquisition, ...

on Baystreet.ca

Regulators Take Further Steps to Expand the Medical CBD Industry

Regulators Take Further Steps to Expand the Medical CBD Industry

on PR Newswire - PRF

Psilocybin Mushrooms Quickly Emerging as Powerful Way to Treat Depression and Addiction

Psilocybin Mushrooms Quickly Emerging as Powerful Way to Treat Depression and Addiction

on Financial News Media

Psilocybin Mushrooms Quickly Emerging as Powerful Way to Treat Depression and Addiction

Psilocybin Mushrooms Quickly Emerging as Powerful Way to Treat Depression and Addiction

on PR Newswire - PRF

Craft Cultivators Amass Plaudits as the Cannabis Industry Swells

Craft Cultivators Amass Plaudits as the Cannabis Industry Swells

on PR Newswire - PRF

Canadian icons come together: Canopy Growth and Drake launch new cannabis wellness company

Canadian icons come together: Canopy Growth and Drake launch new cannabis wellness company

on PR Newswire - PRF

/R E P E A T -- Canopy Growth to Announce Second Quarter Fiscal 2020 Financial Results/

/R E P E A T -- Canopy Growth to Announce Second Quarter Fiscal 2020 Financial Results/

on PR Newswire - PRF

Canopy Growth to Announce Second Quarter Fiscal 2020 Financial Results

Canopy Growth to Announce Second Quarter Fiscal 2020 Financial Results

on PR Newswire - PRF

Canopy Growth to Announce Second Quarter Fiscal 2020 Financial Results

Canopy Growth to Announce Second Quarter Fiscal 2020 Financial Results

on PR Newswire - PRF

Giant Breakthroughs with Psychedelics is Creating Incredible Investment Opportunities

Giant Breakthroughs with Psychedelics is Creating Incredible Investment Opportunities

on Financial News Media

Giant Breakthroughs With Psychedelics is Creating Incredible Investment Opportunities

Giant Breakthroughs With Psychedelics is Creating Incredible Investment Opportunities

on PR Newswire - PRF

Fashion Meets Flower with Holt Renfrew x Tokyo Smoke Holiday Collaboration

Fashion Meets Flower with Holt Renfrew x Tokyo Smoke Holiday Collaboration

on PR Newswire - PRF

Shifting Regulations Signal of New Horizons for the Cannabis Industry

Shifting Regulations Signal of New Horizons for the Cannabis Industry

on PR Newswire - PRF

Spectrum Therapeutics and Tree of Knowledge Announce Partnership to Educate and Support Healthcare Professionals

Spectrum Therapeutics and Tree of Knowledge Announce Partnership to Educate and Support Healthcare Professionals

on PR Newswire - PRF

Alcohol Consumption Falters as Cannabis Products Generate Appeal

Alcohol Consumption Falters as Cannabis Products Generate Appeal

on PR Newswire - PRF

Cultivators Strive to Match Cannabis Demand as the Industry Maintains its Growth

Cultivators Strive to Match Cannabis Demand as the Industry Maintains its Growth

on PR Newswire - PRF

CannabisNewsBreaks - Canopy Rivers Inc.'s (TSX: RIV) (OTC: CNPOF) Radicle Medical Marijuana Awarded Health Canada Oil License

CannabisNewsBreaks - Canopy Rivers Inc.'s (TSX: RIV) (OTC: CNPOF) Radicle Medical Marijuana Awarded Health Canada Oil License

on NetworkNewsWire

This is the Top Catalyst for CBD Growth Over the Next Five Years

This is the Top Catalyst for CBD Growth Over the Next Five Years

on Financial News Media

This is the Top Catalyst for CBD Growth Over the Next Five Years

This is the Top Catalyst for CBD Growth Over the Next Five Years

on Financial News Media

This is the Top Catalyst for CBD Growth Over the Next Five Years

This is the Top Catalyst for CBD Growth Over the Next Five Years

on PR Newswire - PRF

Canopy Rivers Portfolio Company Awarded Health Canada Oil Licence

Canopy Rivers Portfolio Company Awarded Health Canada Oil Licence

on PR Newswire - PRF

Canopy Growth Corp.

Canopy Growth Corp. engages in the production and sale of medical cannabis. The company offers products including oils and concentrates, soft gel capsules and hemp. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada. (See Full Profile)

Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 23 Full Ratings

Competitors

Name Chg % Market Cap
Aurinia Pharmaceuticals Inc. 7.55% $639.99M
Burcon NutraScience Corp. 6.45% $76.73M
Cipher Pharmaceuticals Inc. 1.67% $31.78M
IBEX Technologies Inc. 0.00% $3.29M
Competitor Data Provided ByCapital Cube Logo